Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
DDDD.L Share News (DDDD)
DDDD Share
Price
DDDD Share
News
DDDD Share
Chat
DDDD Share
Trades
DDDD
Live RNS
DDDD Share
Charts
DDDD Broker
Ratings
DDDD Directors
Deals
DDDD Financial
Diary
DDDD
Fundamentals
DDDD Short
Positions
DDDD
Media
DDDD Company
Research
DDDD Company
Timeline
- There is currently no data for DDDD
4D Pharma posts "exciting" development results from MicroRx
Latest DDDD News
- 4D Pharma losses widen as it spends cash on development activities
21 May 2019 - 4d Pharma Annual Loss Widens On Live Biotherapeutic Development Costs
21 May 2019 - 4d Pharma To Present Data From Thetanix Clinical Study In San Diego
16 May 2019 - 4d Pharma "Delighted" With Progress Being Made On Oncology Programme
29 Apr 2019 - DIRECTOR DEALINGS: 4D Pharma CEO And Chief Scientific Officer Buy
14 Mar 2019 - DIRECTOR DEALINGS: 4d Pharma Non-Exec Chair And Director Buy Shares
13 Mar 2019 - 4D Pharma Reports Reveals MRx0518 Immune System Stimulatory Effect
29 Jan 2019 - 4D Pharma Appoints Two Non-Executives From Xencor And Celgene
8 Jan 2019
Related News
IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM
4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June ...
TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
DDDD.L News
4D Pharma losses widen as it spends cash on development activities
(Sharecast News) - Biotherapeutics development company 4D Pharma reported net assets of £45.8m in its final results on Tuesday, falling from £69.8m ye...
4d Pharma Annual Loss Widens On Live Biotherapeutic Development Costs
LONDON (Alliance News) - 4d Pharma PLC on Tuesday said its loss widened in 2018 on research and development costs as it continued to develop its live ...
4d Pharma To Present Data From Thetanix Clinical Study In San Diego
LONDON (Alliance News) - 4d Pharma PLC on Thursday said it will present the data from the completed phase Ib clinical study of Thetanix for the treatm...
4d Pharma "Delighted" With Progress Being Made On Oncology Programme
LONDON (Alliance News) - 4d Pharma PLC on Monday reported a positive initial phase of one drug trial and the start of another.In a phase I/II trial of...
DIRECTOR DEALINGS: 4D Pharma CEO And Chief Scientific Officer Buy
LONDON (Alliance News) - 4D Pharma PLC on Thursday said Chief Scientific Officer Alex Stevenson purchased 24,896 shares at a price of 91.5 pence each ...
DIRECTOR DEALINGS: 4d Pharma Non-Exec Chair And Director Buy Shares
LONDON (Alliance News) - 4d Pharma PLC on Wednesday said Non-Executive Chair David Norwood and Non-Executive Director Thomas Engelen both purchased sh...
4D Pharma Reports Reveals MRx0518 Immune System Stimulatory Effect
LONDON (Alliance News) - 4D Pharma PLC said Tuesday tests have shown its MRx0518 cancer treatment has "strong immuno-stimulatory effects".Researchers ...
4D Pharma Appoints Two Non-Executives From Xencor And Celgene
LONDON (Alliance News) - 4D Pharma PLC said Tuesday it has appointed two new independent non-executive directors, one a previous chief business office...
Follow the stocks
